Peptic ulceration is caused by an imbalance between:

Laparoscopic repair of perforated gastro-duodenal ulcer

The invention relates to pharmaceutical compositions against peptic ulcer as well as a process for the preparation thereof.

Individual intolerance, peptic ulcer of the stomach or duodenum, history of convulsions, pregnancy, lactation.

Active peptic ulcer (until treated, with medication or surgery)

The use of such compounds in the treatment of diseases, including peptic ulceration, is claimed.

Active peptic ulcer disease, symptomatic gallstones, or portal hypertension.

Actual or potential bleeding sites (e.g. peptic ulcer)

They especially have good therapeutic action on active gastritis, gastric erosion, gastric ulcer, and gastro-duodenal ulcer.

Peptic ulcer symptoms, whether due to a stomach or duodenal ulcer, presents as :

Please Note: Administration of HCl/pepsin is contraindicated in peptic ulcer disease.

Active peptic ulcer, perforation (hole) or bleeding in the gut.

It also minimizes your chance of gastritis and peptic ulcer.

Gastro-duodenal ulcers are refractory diseases and often relapse.

This compound has a selective, persistent and potent antiulcerative effect and hence is useful for treating peptic ulcer.